News 23 avr 2024 BGG from China opens headquarters in Basel BGG is establishing new global headquarters in Basel, from which it plans to grow in Europe and the USA. The Beijing-based company is a supplier ...
News 04 avr 2024 Galderma completes largest IPO on a global level in Q1 Galderma has banked nearly 2.3 billion Swiss francs following its listing on the SIX Swiss Exchange. The pharma firm was therefore responsible fo...
News 17 avr 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
Aktuell 23 avr 2024 BGG aus China eröffnet Hauptsitz in Basel BGG richtet in Basel einen neuen globalen Hauptsitz ein und will von dort aus in Europa und den USA expandieren. Das Pekinger Unternehmen ist ein...
News 13 mar 2024 PSI developing new cancer therapy Researchers from the Paul Scherrer Institute (PSI) have developed a radiopharmaceutical to combat metastatic neuroendocrine tumors. After having ...
News 26 mar 2024 Zurich researchers make cancer therapy effective again Researchers from the University of Zurich and University Hospital Zurich have discovered how mutated blood cancer cells can be made to respond to...
最新 25 déc 2023 瑞士初创公司 Zynnon在呼吸道感染的诊断方面实现突破 Zynnon在诊断病毒性呼吸道感染的技术上实现突破。在医院成功研究后,这家来自大苏黎世地区的公司已开始生产原型。随后还将进行进一步的临床试验。
Evento S-GE Fattori chiave di successo per fare affari in Giappone 23 avr 2024 10:15–12:10 Zürich Suisse
Aktuell 04 avr 2024 Galderma realisiert weltweit grössten Börsengang Die Kotierung an der Schweizer Börse hat Galderma knapp 2,3 Milliarden Franken eingebracht. Damit stellt das Pharmaunternehmen im ersten Quartal ...
News 14 fév 2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
Actualités 14 fév 2024 L’Université de Fribourg découvre un traitement pour combattre la neuroinflammation liée à l’âge Des scientifiques de l’Université de Fribourg ont découvert un mécanisme révolutionnaire qui pourrait atténuer de manière significative la neuroi...
Aktuell 26 mar 2024 Zürcher Forschende machen Krebstherapie wieder wirksam Forschende der Universität Zürich und des Universitätsspitals Zürich haben herausgefunden, wie mutierte Blutkrebszellen wieder auf eine Immunther...
最新 14 aoû 2023 中国生物制药公司百明信康完成1.3亿瑞士法郎融资 中国生物制药公司百明信康的欧洲总部位于瑞士巴塞尔大区。作为C轮融资的一部分,该公司已获得约1.3亿瑞士法郎的融资。据悉,这些资金将用于研发活动、业务拓展计划、新项目和员工招募。
News 29 jan 2024 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
ニュース 02 juin 2023 欧州のバイオテクノロジー企業の20%がスイスに本社を置いていることが判明 Press release IQVIAが実施し、このほど発表された「2023スイスバイオテックレポート」によると、欧州のバイオテクノロジー企業の20%がスイスに本社を置いていることが明らかになりました。さらに、スイス連邦政府、州、地域による投資促進に関する昨年の統計でも、この傾向が続いていることが確認されています。
News 22 déc 2023 Zynnon hits milestone in the diagnosis of respiratory infections Zynnon has reached a milestone with its technology for diagnosing viral respiratory infections. Following successful studies in hospitals, the co...
News 19 déc 2023 Top Stories from Western Switzerland (October-December 2023) From achieving top rankings in global innovation to making significant advancements in healthcare and technology, discover Western Switzerland's ...